FDA may approve ketamine spray for depression

The FDA may be on the verge of approving the first new treatment for depression in decades. It involves a form of ketamine used as a nasal spray. Dr. Jon LaPook explains.

Categories: National, US & World News

Leave a Reply

Your email address will not be published. Required fields are marked *